Clinical and Experimental Pharmacology and Physiology Issues Research Articles in July 2022 Edition
June 20, 2022
June 20, 2022
TUGGERAH, Australia, June 20 -- Clinical and Experimental Pharmacology and Physiology, a peer-reviewed journal from the High Blood Pressure Research Council of Australia, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and Australian Physiological Society, published research articles, including the following topics, in its July 2022 edition:
ORIGINAL ARTICLES:
* Inhibition of mTOR by temsirolimus overcomes radio-resistance in nasophar . . .
ORIGINAL ARTICLES:
* Inhibition of mTOR by temsirolimus overcomes radio-resistance in nasophar . . .